| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年8月 |
Autoimmunity Diagnostics Market – Global Forecast To 2031
本調査レポートは、自己免疫疾患診断市場を製品別（消耗品および機器）、検査タイプ別（ルーチン検査、炎症検査、自己抗体および免疫学的検査、尿検査、その他の検査）、疾患タイプ別（全身性自己免疫疾患および臓器特異的自己免疫疾患）、エンドユーザー別（臨床検査室、病院・診療所、その他のエンドユーザー）、地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）に分類しています。レポートは、自己免疫疾患診断市場の成長に影響を与える推進要因、制約要因、機会、課題など、主要な要因に関する詳細な情報を網羅しています。主要業界プレーヤーの徹底的な分析により、各社の事業概要、ソリューション、主要戦略、買収、契約に関する洞察が得られています。自己免疫疾患診断市場に関連する新製品の発売や最近の動向についても解説しています。本レポートは、自己免疫疾患診断市場エコシステムにおける新興企業の競合分析も網羅しています。
自己免疫疾患診断市場は、2025年の55億7,000万米ドルから2031年には89億8,000万米ドルに達し、予測期間中は年平均成長率（CAGR）8.3%で成長すると予測されています。この成長は、自己免疫疾患の有病率の上昇、早期診断への意識の高まり、そしてマルチプレックス免疫測定やバイオマーカーを用いた検査といった技術の進歩によって牽引されています。さらに、自動化プラットフォームの導入拡大と政府の支援策も、検査件数の増加と診断精度の向上に貢献しています。
The autoimmune disease diagnosis market is projected to reach USD 8.98 billion by 2031 from USD 5.57 billion in 2025, at a CAGR of 8.3% during the forecast period. This growth is driven by the rising prevalence of autoimmune disorders, increasing awareness of early diagnosis, and technological advancements such as multiplex immunoassays and biomarker-based tests. Additionally, the growing adoption of automated platforms and supportive government initiatives contribute to increased testing volumes and improved diagnostic accuracy.
The key players in the market are Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), Grifols S.A. (Spain), Werfen S.A. (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Exagen Inc. (US), Trinity Biotech plc (Ireland), Tecan Group Ltd. (Switzerland), Danaher Corporation (US), BIOSYNEX SA (France), QuidelOrtho Corporation (US), Revvity, Inc. (US), bioMérieux SA (France), DiaSorin S.p.A. (Italy), Becton, Dickinson and Company (US), SD Biosensor, INC. (Korea), Cambridge Life Sciences Ltd (UK), A. Menarini Diagnostics s.r.l (Italy), Sebia (France), KRONUS (US), Erba Group (Czech Republic), AESKU.GROUP GmbH (Germany), Medsource Ozone Biomedicals Pvt. Ltd. (India), and Epitope Diagnostics Inc. (US).
autoimmune-disease-diagnosis-market-Overview
Reasons to buy this report:
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall autoimmune disease diagnosis market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (High incidence of autoimmune diseases, rising awareness related to early disease diagnosis, growing number of r&d activities for innovative diagnostic solutions, advancements in diagnostic technologies), restraints (high capital requirements), opportunities (utilization of biosensors for autoimmune disease diagnosis, growth potential of emerging economies, growing number of reagent rental agreements), and challenges (complexities associated with diagnosis of autoimmune diseases, shortage of skilled professionals) influencing the growth of the autoimmune disease diagnosis market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the autoimmune disease diagnosis market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the autoimmune disease diagnosis market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the autoimmune disease diagnosis market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Revvity, Inc. (US), Thermo Fisher Scientific Inc. (US), and Siemens Healthineers AG (Germany).